Additional clearance furthers Eclipse product growth of popular platelet-rich plasma kits
DALLAS, June 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, announced it is expanding its Eclipse PRP® product line in Canada.
Recently, Health Canada cleared Eclipse PRP® (Health Canada Lic.#99292) products. The company is now offering Eclipse PRP® HC featuring a 22 mL high-concentration tube. The HC tube yields an average of ~11 mL of platelet-rich plasma. The Eclipse PRP® system is also available with the standard 11 mL tube that yields approximately ~6 mL of PRP.
Both tubes can be processed from the Eclipse Easy Spin™ Centrifuge (Health Canada Lic.#99293). Equipped with custom fit tube holders, the centrifuge offers PRP providers the flexibility to process 22 mL or 11 mL tubes from one unit.
Eclipse PRP® is an autologous system that allows for the safe preparation of pure PRP with optimal platelet recovery or 87% ± 10%. Virtually, all red blood cells (RBC) are eliminated from PRP for reduced inflammation. The concentration of pro-inflammatory Granulocytes (GRs) are also highly reduced. This system has been safely used in hundreds of thousands of procedures worldwide.
“Eclipse PRP® products are global best sellers. The system is fast, effective, simple to use, requires minimal steps, and allows for customizable concentration,” said Tom O’Brien, CEO and Founder of Eclipse. “Our company is pleased to now provide the 22 mL PRP kit along with the 11 mL PRP kit to practices in Canada though our distribution partner Salient Medical Solutions.”
“Both tubes offer an incredible value providing both quantity and quality,” said Jay Herman, President of Salient Medical Solutions. “Eclipse PRP® is an innovative system that is not only easy to use, it is available at a lower price per mL when compared to many other PRP kits on the market.”
Eclipse PRP® has been featured in U.S. and International media for its leading-edge cellular collection technology and remarkable results. Read more
Eclipse MicroPen® Elite Cleared by Health Canada
Regulatory clearance fuels global growth of award-winning micro-needling device
DALLAS, April 26, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical manufacturer, is pleased to announce clearance by Health Canada for the the Eclipse MicroPen® Elite, an advanced medical-grade, automated, cordless, high-speed micro-needling device.
Clinics utilize the MicroPen® Elite to aid in the improved appearance of wrinkles, stretch marks, acne scars, skin tone and texture. The device can be used on various areas including the face, neck, décolleté, arms, hands and beyond.
“We’re excited to bring the Eclipse MicroPen® Elite to the Canadian market,” said Tom O’Brien, CEO and Founder of Eclipse. “The micro-needling pen’s popularity, reliability and clinical efficacy has been highly sought after by Canadian skin-care professionals at American medical conferences. For the first time, it can now be sold though our distribution partner Salient Medical Solutions.”
“Salient’s commitment to sourcing innovative and advanced medical technology continues with its alliance with Eclipse,” says Jay Herman, President of Salient Medical Solutions. “The micro-needling pen, company’s future innovations and commitment to regulatory compliance made our decision to partner with Eclipse clear.”
The automated micro-needling pen is a safe alternative to common skin resurfacing tools, such as lasers and dermal rollers. The MicroPen® Elite, which won THE Aesthetic Industry Award for “Best Micro-Needling Device,” is affordable, portable, effective, requires minimal to no down time and provides natural-looking results.
“With the Health Canada clearance and growing global distribution of Eclipse MicroPen® Elite, we look forward to reaching a new consumer base,” said Tom Goslau, Director of International Sales. “The device will allow skin-care providers a new and more effective way to address the evolving needs of aging consumers.” Read more
Eclipse Announces John Ohanesian as Strategic Advisor
Leading medical supply, aesthetic provider appoints former Bosley CEO to meet, enhance growth demands in domestic and international marketplace
DALLAS, March 3, 2017 /PRNewswire/ — Eclipse Aesthetics®, LLC., an award-winning manufacturer of medical and aesthetic supplies, is pleased to announce the addition of John Ohanesian, former CEO of Bosley®, as a key strategic advisor.
Mr. Ohanesian has an excellent reputation for transforming companies into worldwide success stories. During his 20-year tenure as the CEO of Bosley®, he grew the company into 90 markets. In his recent venture as the CEO of Cosmedica, LLC. and as a strategic advisor, Mr. Ohanesian has strategically helped companies develop markets in the retail medicine space with a focus on aesthetics, beauty and wellness.
“This is an exciting time of vast growth for our company,” said Tom O’Brien, Founder and CEO of Eclipse Aesthetics®, LLC. “Mr. Ohanesian is an excellent and integral addition to our ever-expanding company. This new role is a significant and exciting step forward as Eclipse continues to design, develop and market leading-edge products for the United States, Canada and global market.”
“I am happy to be joining Eclipse, an outstanding distribution enterprise with a 25-year heritage,” said Mr. Ohanesian. “In my role as a strategic advisor, I foresee many opportunities in which my 27 years within the health, wellness and appearance medicine verticals will provide tremendous potential to further grow these sectors. In addition, we will identify and bring forth new and proven scientific-based products and technologies.”
“As a leader in the medical aesthetic industry, it’s essential to have proper personnel meet the company’s growth,” said Mr. O’Brien. In addition, the Eclipse sales division is also expanding to meet the increasing demands of the supplier’s top-selling products, which includes: Eclipse PRP®, platelet-rich plasma kits; Eclipse MicroPen®, micro-needling device; Theradome™, hair-growth technology; dEp Patch™, micro-current patch and mask systems; and NEWA®, hand-held home-use RF device, among others. Read more
Eclipse Launches NEWA®, Home-Use RF Skin-Care System
Leading Aesthetic Provider Exclusive U.S. Distributor to Skin-Care Professionals of First FDA-Cleared, Energy-Based Wrinkle-Reduction Device
DALLAS, Dec. 7, 2016 /PRNewswire/ — Eclipse Aesthetics®, LLC., a leading aesthetic and medical supply company, proudly announces it has partnered with EndyMed Medical Ltd., a pioneer and leader in multi-source radiofrequency (RF) technology products, to offer the NEWA® through medical aesthetic professionals. The energy-based RF device is the first of its kind to receive FDA clearance for aesthetic home-use.
The NEWA®, a non-invasive skin-care system, is based on EndyMed’s patented 3DEEP® RF technology. The device is clinically proven to reduce mild to moderate facial wrinkles utilizing the revolutionary technology. NEWA® delivers controlled energy into the skin, which can aid in the reduction of fine lines and wrinkles.
The innovative system was developed by an internationally renowned dermatologist and received the Edison Innovation Award for 2013 in the Medical Scientific Category. NEWA® is an ideal complement to in-office treatment devices including Eclipse Firma™ and Eclipse Skinfinity RF™. The device enables consumers to safely enhance results in the comfort and convenience of their homes. Consumers can personalize their regimen with the NEWA® app, available for iPhone and Android users.
“Eclipse is very excited to be launching this ground-breaking technology in the United States,” said Tom O’Brien, CEO of Eclipse. “It’s a clinically proven system that eclipses other home-use devices. It empowers consumers to supplement and enhance the results of in-office procedures.” The award-winning device is now available from select dermatologists, plastic surgeons and medical spas. “The time for NEWA® is now,” he added.
“We’re pleased to partner with Eclipse to offer the first FDA-cleared RF device for home-use in the U.S.,” stated Amy Kamin, CEO of EndyMed USA. “This device is like no other available and will solidify our leading technological position in the world’s RF-based home-use devices market.”
Studies reveal skin loses 1-2% of its collagen annually after the age of 30. Over time, collagen loss can lead to wrinkles and older-looking skin. While some creams advertised for anti-aging may aid in the surface appearance, RF devices, such as NEWA®, work deep under the skin’s surface where wrinkles begin to form.
Eclipse Aesthetics®, LLC. provides solutions to the U.S. and International aesthetic and medical communities. Eclipse offers a portfolio of products including: Eclipse PRP®, platelet rich-plasma kits; Eclipse MicroPen®, micro-needling technology; and Eclipse Skinfinity RF™, among others. www.EclipseMed.com
Eclipse Aesthetics Expands Popular PRP Product Line
DALLAS, Aug. 18, 2016 /PRNewswire/ — Eclipse, a leading medical supply company, is enhancing and expanding the Eclipse PRP® product line to meet the growing needs of practices offering platelet-rich plasma procedures.
The company is introducing the all-new Eclipse PRP® HC kit featuring a 22 mL high-concentration tube. The new tube will yield an average of ~11 mLs of platelet-rich plasma. In addition,
the popular 10 mL tube has been increased to an 11 mL size that yields approximately ~6 mLs of PRP.
Also being released tandem with the PRP tubes, the company is offering the all-new Eclipse Easy Spin® Centrifuge. With multiple-size tube holders, the centrifuge offers flexibility for platelet-rich plasma providers who want to process the new, larger 22 mL or 11 mL tubes from one unit.
The Eclipse PRP® system is fast, effective, simple to use, requires minimal steps, and allows for customizable concentration. “The new Eclipse PRP® HC tube, larger standard tube and additional centrifuge will allow practices more options to meet the varying needs of their patients,” said Tom O’Brien, CEO and Founder of Eclipse. “Both tubes also offer an incredible value. You get both quantity and quality. Eclipse PRP is a lower price per mL when compared to many other PRP kits on the market.”
Eclipse PRP® is an autologous system that has been featured in national media. The easy-to-use, all-in-one kits allow physicians to prepare platelet-rich plasma. The PRP is optimally concentrated with the highest platelet yield of ~90%. These systems have been safely used in hundreds of thousands of procedures worldwide. Read more.
Eclipse Aesthetics® Partners to Offer Clearista® Pro Line
DALLAS, March 11, 2016 /PRNewswire/ — Eclipse Aesthetics®, LLC has formed a partnership with Skincential Sciences, a medical diagnostics company in southern California. Eclipse will serve as the exclusive distributor for ClearistaPRO™, specially formulated products to safely and effectively remove biomarkers from tissue. The innovative product line is featured on The Doctors TV show March 14, 2016.
“Eclipse is pleased to be distributing the professional Clearista® product line! The line is designed to improve the skin, soften and aid in removal of benign pigmented lesions with its proprietary refining pen and retexturing gel,” said Tom O’Brien, CEO and Founder of Eclipse Aesthetics®.
The ClearistaPRO® system is based on years of extensive research and clinical trials. In 2013, the company’s hard work resulted in a patent for a highly effective product that aids in the skin’s natural exfoliation process and reduces the appearance of rough patches, skin bumps (e.g. keratosis pilaris), surface blemishes and pigmented surface spots (e.g. seborrheic keratosis).
“We are delighted to be partnering with Eclipse Aesthetics® to bring the Clearista® brand to their customers,” Russ Lebovitz, Skincential Sciences CEO. “Skincential Sciences is very proud of the proprietary nature of our Clearista® formula and the many resurfacing benefits it provides to all skin types. Eclipse Aesthetics has built a strong, reputable organization by bringing quality products to the market and we look forward to adding this strong product offering.” Read more.
Eclipse Aesthetics Announces Key Hires to Meet Company Growth
DALLAS, Oct. 27, 2015 /PRNewswire/ — Eclipse Aesthetics, LLC is pleased to announce the addition of key team members to the aesthetic supply company. The business is expanding to meet increasing demands due to new product development and sales growth.
Shawn Beddes joins the company as a Quality Assurance Manager. He’s integral to the team as Eclipse Aesthetics offers additional Food and Drug Administration (FDA) registered products. He has over 13 years of experience in the medical device and pharmaceutical manufacturing industries. “I look forward to working with Eclipse to help fast track our ISO 13485 certification as the company continues to rise to new heights,” he said.
Eclipse Aesthetics also welcomes Melanie Seagraves as a Quality Assurance Process Analyst overseeing the FDA and ISO Compliant Quality Systems. She has a Bachelor’s of Science degree in Biology and experience working for a major medical device manufacturer. She’s well versed in handling non-conforming products, document control, records management and corrective actions.
–>”We’re excited to see our Quality Assurance Department and Eclipse Aesthetics’ team grow,” said Tom O’Brien, CEO of Eclipse Aesthetics. “As a leader in the aesthetic industry, it’s essential to have proper protocols and personnel. The Quality Assurance team makes certain all FDA regulations are met and every product meets the company’s best-in-class standards.” Read more.
Eclipse Aesthetics, LLC Files Suit Against RegenLab USA, LLC
DALLAS, July 23, 2014 /PRNewswire/ — On Tuesday, July 1, 2014, Eclipse Aesthetics, LLC (“Plaintiff”) filed suit in the 116th Judicial District Court in Dallas, Texas, against RegenLab USA, LLC (“Defendant”) for Tortious Interference with Current and Prospective Business Relationships through false and misleading actions, fraud, fraud-in-the-inducement, business interference, tortious interference; and, Business Disparagement through libel, disparagement, defamation, misrepresentation, and violating the false/deceptive advertising laws (among other laws) that are valid in every state in the United States.
Eclipse Aesthetics is a developer and supplier of aesthetic-based products for cosmetic procedures including Platelet Rich Plasma (Eclipse PRP™). RegenLab USA designs, develops, manufactures, and commercializes Platelet Rich Plasma (PRP) for professional markets.
As a result of RegenLab USA knowingly sending a false, fraudulent, and deceptive Promotional E-mail that was intentionally designed to disparage Eclipse and Eclipse PRP™ while damaging its standing within the medical care community, Eclipse has filed suit against RegenLab USA.
CONTACT: Info@eclipsemed.com, 800-759-6876
Eclipse Aesthetics Launches NEW Safety Applicator For the Eclipse MicroPen™
Eclipse Aesthetics, LLC, makers of the popular Eclipse MicroPen® is excited to launch its new fluid resistant vented Application Tip. Featured on The Doctors, the new vented Turbo Safety Cartridge makes the Eclipse MicroPen™ the safest and most effective single use micro-needling system available. The Eclipse MicroPen® is a cutting-edge, surgical grade micro-needling device designed for the improvement of stretch marks, acne scars, fine lines and wrinkles.
The new Safety Applicator available exclusively by Eclipse Aesthetics provides significant advances in micro-needling technology:
“Micro-needling is becoming more popular, due to its safe, predictable results. There are many brands of micro-needling devices available but the unique features of the Safety Applicator Tip are what separates the Eclipse MicroPen® from the other needling devices. The unique feature of the needle applicator with fluid barrier design reduces the risk of cross-contamination exponentially even as it oscillates back and forth at a very high rate of speed. Patient safety and efficacy is most important to me which is why the Eclipse MicroPen® is the only micro-needling device I feel comfortable using and delegating.” – Tess Mauricio, MD Read more.
Leading Edge Laser Technology Comes To Zimmet Vein and Dermatology
Steven E. Zimmet, M.D. Director of Zimmet Vein and Dermatology of Austin, Texas announces the introduction of the first Tri-Beam Q-Switch laser system available in Texas. The Tri-Beam Q-Switched Nd:YAG laser is specially designed for tattoo removal, treatment of pigmented lesions, melasma, acne, and non-ablative skin rejuvenation. The Tri-Beam also delivers a means to improve skin tone and texture. Read more.
Announcing – Equinox CO2 fractional laser by Eclipse Aesthetics, LLC.
Equinox CO2 fractional laser is capable of aiding the physician to deliver consistent and dramatic, visible improvement to the patient in a single 30-minute treatment session.
Dallas, Texas, BUILT TO LAST AND TO PERFORM, Equinox CO2 fractional laser is capable of aiding the physician to deliver consistent and dramatic, visible improvement to the patient in a single 30-minute treatment session. Equinox is designed to effectively deliver superior skin resurfacing and rejuvenation results with excellent improvement of fine lines and wrinkles, acne, surgical scars, skin pigmentation or discoloration, sun damage, pre-cancerous and benign lesions.
Equinox boasts the flexibility of a fractional CO2 laser with enhanced ability to infinitely adjust the dot pitch or laser beam spacing providing simplicity and accuracy for outstanding patient results. Equinox is exclusively manufactured for Eclipse Aesthetics, LLC.
Smooth Cool HR/SR Light Based Hair Removal
Eclipse, the leading US national distributor of advanced medical and aesthetic devices, introduces Smooth Cool HR/SR, a world-class technology that’s proven to be a best in class player in the light based hair removal market. Read more.
5916 Stone Creek Dr. Suite #120
The Colony, TX 75056